Clinical Trials
1.2k
Active:44
Completed:549
Trial Phases
6 Phases
Early Phase 1:4
Phase 1:10
Phase 2:91
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (955 trials with phase data)• Click on a phase to view related trials
Not Applicable
741 (77.6%)Phase 2
91 (9.5%)Phase 4
72 (7.5%)Phase 3
37 (3.9%)Phase 1
10 (1.0%)Early Phase 1
4 (0.4%)Exercise Intervention as Treatment for People Using Cannabis (ExIT-C)
Not Applicable
Recruiting
- Conditions
- Cannabis AbuseCannabis DependenceCannabis Use Disorder
- First Posted Date
- 2025-07-29
- Last Posted Date
- 2025-07-29
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 60
- Registration Number
- NCT07091292
- Locations
- 🇭🇰
Queen Mary Hospital, Hong Kong, Hong Kong
Nurse-supported Mobile App for Self-help CBT-I in Informal Cancer Caregivers
Not Applicable
Not yet recruiting
- Conditions
- Insomnia ChronicCancer Caregivers
- First Posted Date
- 2025-07-28
- Last Posted Date
- 2025-07-28
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 208
- Registration Number
- NCT07089797
A Double-Blind, Sham-Controlled Trial Investigating Individualized Alpha Neurofeedback Plus Cognitive Training in Paediatric Brain Tumour Survivors
Not Applicable
Not yet recruiting
- Conditions
- Brain Tumor, Primary
- First Posted Date
- 2025-07-25
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 50
- Registration Number
- NCT07085494
Evaluating the Efficacy of a Text Messaging-based Shisha Smoking Cessation Intervention
Not Applicable
Not yet recruiting
- Conditions
- InterventionControl
- First Posted Date
- 2025-07-17
- Last Posted Date
- 2025-07-17
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 100
- Registration Number
- NCT07070154
- Locations
- 🇭🇰
Room 212, New Clinical Building, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, Hong Kong
Use of Shock Wave Therapy for Neo-Vascularisation in Non-critical Coronary Artery Disease: Validation by Quantitative Cardiac MRI Perfusion
Not Applicable
Recruiting
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2025-07-16
- Last Posted Date
- 2025-07-16
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 100
- Registration Number
- NCT07068399
- Locations
- 🇭🇰
HKU Li Ka Shing Faculty of Medicine, Hong Kong, Hong Kong
- Prev
- 1
- 2
- 3
- 4
- 5
- 231
- Next
News
No news found